Jeg mener, at OTC-instrumenter kan give problemer, fordi de ikke er likvide, prisen er vanskelig at vurdere, og de omfatter udækkede modpartsrisici.
I believe that OTC instruments could lead to problems, because they are not liquid, the price is difficult to estimate and they entail uncovered counterparty risks.